Cellectis SA
F:ZVA
Cellectis SA
F:ZVA
Price:
2.764
EUR
Market Cap:
€276.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cellectis SA
F:ZVA
|
FR |
|
Douyu International Holdings Ltd
F:DY8
|
CN |
|
Bluestone Jewellery and Lifestyle Ltd
NSE:BLUESTONE
|
IN |
|
C
|
Com7 PCL
SET:COM7
|
TH |
|
H
|
Homology Medicines Inc
XBER:35H
|
US |
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
US |
|
Watsco Inc
F:WC30
|
US |
|
E
|
EnerSys
DUS:FDN
|
US |
|
A
|
Amada Co Ltd
F:AA2
|
JP |
|
A
|
Aspo Oyj
F:ZYD
|
FI |
|
I
|
IDT Corp
XMUN:IDC2
|
US |
Wall St Price Targets
ZVA Price Targets Summary
Cellectis SA
Cellectis SA
Wall Street analysts forecast ZVA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ZVA is 5.821 EUR with a low forecast of 5.764 EUR and a high forecast of 5.992 EUR.
Lowest Forecast
Price Target
5.764
EUR
109% Upside
Average Forecast
Price Target
5.821
EUR
111% Upside
Highest Forecast
Price Target
5.992
EUR
117% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZVA's stock price target?
Price Target
5.821
EUR
5.821
EUR
According to Wall Street analysts, the average 1-year price target for ZVA is 5.821 EUR with a low forecast of 5.764 EUR and a high forecast of 5.992 EUR.
What is the Revenue forecast for Cellectis SA?
Projected CAGR
21%
21%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 21%.
